Matthew Krueger Weighs in on Federal Health Care Fraud Enforcement Trends
January 12, 2026
Report on Medicare Compliance
Foley & Lardner LLP partner Matthew Krueger assessed trends shaping federal health care fraud enforcement in the Report on Medicare Compliance article, “Outlook 2026: Enforcers Will Strikes New and Old Targets; ‘Resources Are a Wild Card.‘”
Kruger said that the return of the U.S. Department of Justice’s False Claims Act (FCA) working group signifies that “the FCA remains a significant priority.”
“A record number of qui tam cases were filed last year,” he added.
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.